Provided by Tiger Fintech (Singapore) Pte. Ltd.

Krystal Biotech Inc.

132.09
+2.071.59%
Post-market: 132.090.00000.00%19:27 EDT
Volume:354.14K
Turnover:46.39M
Market Cap:3.82B
PE:31.79
High:132.35
Open:130.86
Low:127.99
Close:130.02
Loading ...

Solid Earnings Reflect Krystal Biotech's (NASDAQ:KRYS) Strength As A Business

Simply Wall St.
·
01 Mar

Krystal Biotech Price Target Maintained With a $221.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb

Krystal Biotech's Skin Disorder Treatment Recommended by European Medicines Agency Committee

MT Newswires Live
·
28 Feb

Krystal Biotech Gets CHMP Backing for Vyjuvek Approval

Dow Jones
·
28 Feb

Krystal Biotech receives positive CHMP opinion for VYJUVEK

TIPRANKS
·
28 Feb

BRIEF-EMA's CHMP Says Opinion Recommending Marketing Authorisation For Leqembi Not Need To Be Updated

Reuters
·
28 Feb

Press Release: Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK(R) for the Treatment of Dystrophic Epidermolysis Bullosa

Dow Jones
·
28 Feb

Ema's Chmp: Vyjuvek (Beremagene Geperpavec) Receive Positive Opinion to Treat Wounds in Patients of All Ages With Dystrophic Epidermolysis Bullosa

THOMSON REUTERS
·
28 Feb

Ema: Recommended Granting a Marketing Authorisation in EU for Vyjuvek to Treat Wounds in Patients of All Ages With Dystrophic Epidermolysis Bullosa

THOMSON REUTERS
·
28 Feb

Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
26 Feb

Why Krystal Biotech (KRYS) Might be Well Poised for a Surge

Zacks
·
25 Feb

Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term

Zacks
·
24 Feb

Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know

Zacks
·
22 Feb

Stock Track | Krystal Biotech Soars 5.61% Pre-Market on Stellar Q4 Earnings and Positive Analyst Outlook

Stock Track
·
20 Feb

Stock Track | Krystal Biotech Inc. (KRYS) Soars 5.02% in Pre-Market on Positive Earnings and Analyst Outlook

Stock Track
·
20 Feb

Krystal Biotech price target raised to $215 from $206 at Citi

TIPRANKS
·
20 Feb

Krystal Biotech Is Maintained at Buy by Chardan Capital

Dow Jones
·
20 Feb

3 US Growth Companies With High Insider Ownership Expecting Up To 68% Earnings Growth

Simply Wall St.
·
20 Feb

Krystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com
·
20 Feb

Q4 2024 Krystal Biotech Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Feb